Author of the publication

miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions.

, , , , , , , , , , , , , , , , , and . Nucleic Acids Res., 42 (Database-Issue): 78-85 (2014)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Enhancing performance of feedback-Based QoS scheduling for video delivery over WLANs., , and . Comput. Commun., (2017)An Analysis of the In-Out BRDF Factorization for View-Dependent Relighting., , and . Comput. Graph. Forum, 27 (4): 1137-1145 (2008)miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions., , , , , , , , , and 8 other author(s). Nucleic Acids Res., 42 (Database-Issue): 78-85 (2014)Level-of-detail representation of bidirectional texture functions for real-time rendering., , , , , , and . SI3D, page 187-194. ACM, (2005)DPRP: a database of phenotype-specific regulatory programs derived from transcription factor binding data., , , , , and . Nucleic Acids Res., 42 (Database-Issue): 178-183 (2014)rMAPS: RNA map analysis and plotting server for alternative exon regulation., , , , and . Nucleic Acids Res., 44 (Webserver-Issue): W333-W338 (2016)Preliminary physician and pharmacist survey of the National Health Insurance PharmaCloud system in Taiwan., , , , , , and . Comput. Methods Programs Biomed., (2017)DiseaseConnect: a comprehensive web server for mechanism-based disease-disease connections., , , , , , , , , and 3 other author(s). Nucleic Acids Res., 42 (Webserver-Issue): 137-146 (2014)Fabrication of biocompatible ordered iron oxide nanopillars for the observation of cell behavior., , and . NEMS, page 47-52. IEEE, (2017)A Multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate Coronavirus disease 2019 (COVID-19), , , , , , , , , and 9 other author(s). (July 2020)